Post-earnings recap
Reported
Mon, Apr 20, 2009
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Boston Scientific reported an EPS of $0.19, which was significantly above expectations, resulting in a positive surprise. However, the stock fell by 3.66% following the earnings report, indicating that investors may have been looking for more comprehensive guidance or details on revenue performance, which were not provided.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.19 | N/A | +57.02% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.
Est. EPS
—
Est. Rev
—
Impl. Move
—